A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
about
A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cellsAchieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expressionThe impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II moleculesThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain.Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DMIi chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes.Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles.HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR moleculesNovel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6pFunctionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexesMasking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule.Class II antigen processing compartments and the function of HLA-DM.Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules.The endogenous pathway of MHC class II antigen presentation.Antigen presentation by MHC class II molecules.Invariant chain induces a delayed transport from early to late endosomes.Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM.
P2860
Q26747063-16F15BA3-920A-4C9C-93F7-8A1CC30BF22BQ28273723-0B585082-2BDE-43E8-9B91-B6E674D8146AQ29037067-DCC26A1E-D5A1-4B8F-9E01-03716EE688BDQ30444065-AA8F88E0-B2E0-4140-A795-164C149EE067Q33613002-EF6AAF8B-C6E2-49AE-A3DB-88301A6A75F3Q33815425-9FB12C6A-73C8-49C6-811E-BA5562B2796DQ33878348-976B73A8-8D0D-4251-884F-35EB21F2B8CBQ34083338-6F10DF46-E19E-4280-8C8C-264A1834E032Q36274077-899CFE6D-191F-45D4-933E-2B8089DBEEB3Q36364390-364C7C89-5177-4D0A-A692-88D79E746E0BQ36364770-61EEB5F0-5BCC-40D1-B655-F08E42F28A2AQ36377428-CFEAD1E3-67A5-410A-A131-7604E95CB534Q36380786-6452F318-63A6-404D-A53D-7BA5A7C288BCQ36561563-693E3A7B-D21B-4709-98A2-5561346B9F09Q39724282-E8B1EF2A-D4D2-453D-AAF9-9B8F86BF3AEFQ39822860-1320CEE8-29DB-482D-9EBC-1969596D621DQ41091901-664A0A4C-A702-422B-A1C9-1913DE13E4E8Q41168208-3B4CCDDB-DA61-4315-9861-FD72E18C7D1EQ41168212-ACA8DC9E-B02C-4D16-A1A0-79A894426595Q41359341-6873521D-3336-4E97-AF0F-4FBD69B6DE5BQ41370290-CD010070-427F-42DF-9422-28CE1ACE76C8Q46972584-1646E931-B173-405D-8502-D517025209ED
P2860
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
A mutant human histocompatibil ...... with invariant chain peptides.
@ast
A mutant human histocompatibil ...... with invariant chain peptides.
@en
type
label
A mutant human histocompatibil ...... with invariant chain peptides.
@ast
A mutant human histocompatibil ...... with invariant chain peptides.
@en
prefLabel
A mutant human histocompatibil ...... with invariant chain peptides.
@ast
A mutant human histocompatibil ...... with invariant chain peptides.
@en
P2093
P2860
P356
P1476
A mutant human histocompatibil ...... with invariant chain peptides.
@en
P2093
P2860
P304
P356
10.1084/JEM.179.2.541
P407
P577
1994-02-01T00:00:00Z